View Older Stories View More Recent Stories

Mar 9, 2025 07:32AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Mar 8, 2025 09:19AM REGN DEADLINE MONDAY: ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities

Mar 7, 2025 07:08PM REGN DEADLINE ALERT: Regeneron Pharmaceuticals (REGN) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 10th Deadline in Securities Class Action

Mar 7, 2025 03:44PM MONDAY DEADLINE: Berger Montague Advises Regeneron Pharmaceuticals, Inc. (REGN) Investors to Inquire About a Securities Fraud Class Action by March 10, 2025

Mar 6, 2025 06:14PM REGN DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - REGN

Mar 6, 2025 03:44PM SHAREHOLDER REMINDER: Berger Montague Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of the March 10, 2025 Deadline

Mar 5, 2025 06:09PM REGN DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - REGN

Mar 3, 2025 06:39PM REGN DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - REGN

Mar 3, 2025 03:32PM Regeneron's (REGN) Transparency Questioned as Investors Sue Over Eylea Pricing Practices- Hagens Berman

Mar 2, 2025 01:00PM REGN IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in

Mar 2, 2025 08:33AM Regeneron Pharmaceuticals, Inc. (REGN) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Mar 1, 2025 01:55PM REGN DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securit

Mar 1, 2025 08:21AM Faruqi & Faruqi Reminds Regeneron Pharmaceutials Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN

Feb 28, 2025 01:50PM REGN FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Sec

Feb 28, 2025 07:00AM Regeneron (REGN) reports Linvoseltamab Recommended for EU Approval by the CHMP

Feb 27, 2025 01:45PM REGN DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities

Feb 27, 2025 01:42PM Regeneron Pharmaceuticals (REGN) Faces Mounting Pressure on Sales, Legal Fronts- Hagens Berman

Feb 26, 2025 01:40PM REGN DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Actio

Feb 26, 2025 07:02AM Regeneron (REGN): Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma

Feb 26, 2025 02:36AM Berger Montague Reminds Regeneron Pharmaceuticals (REGN) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by March 10, 2025

Feb 25, 2025 06:19PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Feb 24, 2025 06:18PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Feb 24, 2025 03:01PM Regeneron (REGN): Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial

Feb 24, 2025 11:33AM DEADLINE APPROACHING: Berger Montague Advises Regeneron Pharmaceuticals, Inc. (REGN) Investors to Inquire About a Securities Fraud Class Action by March 10, 2025

Feb 22, 2025 01:01PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 22, 2025 08:01AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Feb 21, 2025 12:56PM ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 20, 2025 03:40PM Regeneron Pharmaceuticals (REGN) Faces Mounting Pressure on Sales, Legal Fronts- Hagens Berman

Feb 20, 2025 11:44AM Regeneron Pharmaceuticals, Inc. (REGN) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Feb 19, 2025 03:17PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 19, 2025 11:33AM REGENERON PHARMACEUTICALS (REGN) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by March 10, 2025

Feb 18, 2025 07:04PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Feb 18, 2025 03:15PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 17, 2025 12:03PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Feb 17, 2025 02:36AM REGENERON PHARMACEUTICALS, INC. (REGN) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By March 10, 2025

Feb 15, 2025 09:18AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Feb 13, 2025 01:49PM Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman

Feb 12, 2025 01:00PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 11, 2025 02:28PM Faruqi & Faruqi Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN

Feb 11, 2025 07:01AM Regeneron (REGN): Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma

Feb 10, 2025 02:36AM INVESTOR ALERT: Berger Montague Advises Regeneron Pharmaceuticals, Inc. (REGN) Investors to Inquire About a Securities Fraud Class Action by March 10, 2025

Feb 9, 2025 10:19PM ROSEN, A TOP-RANKED LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 9, 2025 08:56AM Faruqi & Faruqi Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN

Feb 8, 2025 10:20PM ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 7, 2025 08:51PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 7, 2025 02:06AM SHAREHOLDER DEADLINE: Regeneron Pharmaceuticals (REGN) Investors Are Reminded of Deadline in Securities Action

Feb 6, 2025 08:46PM ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

Feb 6, 2025 05:19PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals

Feb 6, 2025 04:00PM Analyst Cuts Regeneron Pharmaceuticals (REGN) Price Target After Sales Concerns and Investor Lawsuit- Hagens Berman

Feb 5, 2025 11:51AM Regeneron Pharma (REGN) PT Lowered to $1,045 at RBC Capital

View More Recent Stories View Older Stories